Abbott India soars 20% on strong Q2 results

The stock was locked in upper circuit of 20% at Rs 5,401, also its 52-week high on the BSE.

Abbott India was locked in upper circuit of 20% at Rs 5,401, also its 52-week high on the BSE, after the pharmaceutical company reported a 83% year on year growth in net profit at Rs 137 crore in September 2017 quarter (Q2FY18).

It had reported a profit of Rs 75 crore in the same quarter year ago, and Rs 48 crore in previous quarter. Revenue from the operations grew 29% to Rs 931 crore in Q2FY18 from Rs 721 crore in the corresponding quarter of previous quarter.

Abbott India said the current quarter includes significant recovery of the trade